Skip to main content

Search results

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

Scroll down for content
MSF staff in a mobile medical unit treat a woman in Lebanon.

Lebanon: MSF responds to humanitarian needs amid military escalation

story Sep 24, 2024

News Sep 25, 2024

The world's collective failure on Sudan couldn’t be clearer

Tammam at UN General Assembly

story Sep 26, 2024

5 reasons why abortion is health care

A midwife speaks with a patient at Chingussura health center in Beira, Mozambique.

story Sep 26, 2024

How MSF provides mental health care for migrants and asylum seekers at the US-Mexico border

Migrants and asylum seekers from Bangladesh and Nepal wait for US Border Patrol to pick them up along the unpaved road next to the US-Mexico border wall in Sasabe, Arizona.

News Sep 24, 2024

UN political declaration on antimicrobial resistance must go beyond words on paper

An MSF staff member in a laboratory.

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

6 results

News | Aug 22, 2024

WHO recommends MSF-led endTB clinical trial treatments

Wider use of shorter and effective treatment regimens studied through endTB will help improve care for people with drug-resistant TB worldwide.

Read More
Dr. Muneeba Shaikh, a medical officer sees the results of X-ray of Rehana-28 year old, drug-resistant tuberculosis patient and participant of the endTB-Q trial at endTB clinical trial clinic in Kotri, Pakistan on Monday 29 April 2024.

News | Jul 17, 2024

MSF welcomes Indian rejection of J&J patent application for pediatric TB drug

Decision will allow other drugmakers to help boost the supply of this lifesaving medicine.

Read More
An MSF staff member in India talks to a patient who was part of the EndTB clinical trial to find better treatments for tuberculosis.

News | Jun 25, 2024

Time for $5: An open letter to Danaher employees

Affordable GeneXpert tests would help people have a chance to get tested, treated, and be cured.

Read More
A letter reading "Dear Danaher employee" as part of MSF's Time for $5 campaign.

News | Apr 25, 2024

MSF publishes cost of its TB clinical trial

Transparency on clinical trial costs must become the norm to improve access to medical products worldwide.

Read More
An older patient sits with her grandson at one of MSF's active case-finding sites for tuberculosis.

News | Apr 23, 2024

As Danaher reports earnings, MSF repeats call for $5 GeneXpert tests

Medical testing shouldn't be a luxury. Danaher and Cepheid must drop the price of GeneXpert for low- and middle-income countries

Read More
Protesters holding signs in Washington, DC as part of the Time for $5 campaign.

News | Mar 19, 2024

Help us stop the profiteering on medical tests

Sign the petition to demand drug manufacturers Cepheid and Danaher drop the price of GeneXpert tests for low- and middle-income countries.

Read More
Time for $5
For Donation Inquiries 
See donor options here
 
U.S. Media Inquiries 

Reach out to the press team
 
Non-U.S. Media Inquiries 

Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.